Year: 2025
Type: article
Study design: Case Report
Abstract: Background/Objectives: Krabbe disease (KD) is a hereditary lysosomal disorder whose hallmark is progressive demyelination, with variable involvement of the central nervous system. It is caused by pathogenic variants in the GALC gene that disrupt the function of its gene product, the lysosomal enzyme galactosylceramidase. We analyzed two unrelated cases (one early infantile and one adult) with a clinical suspicion of KD. Methods: We used a combination of biochemical techniques (high-performance liquid chromatography–tandem mass spectrometry), NGS (resequencing gene panels), splicing assays, and molecular modeling to identify and analyze the pathogenicity of the variants underlying the disorder. Results: The two probands were compound heterozygotes for disease-causing variants in the GALC gene, encoding the lysosomal hydrolase galactosylceramidase. Three of the variants were novel and caused aberrant splicing, either by exon skipping (c.908+5G>A and c.1034-1G>C) or by inclusion of a cryptic, deep intronic pseudoexon (c.621+772G>C). The fourth variant was a known missense change (c.956A>G, p.(Tyr319Cys)) with conflicting interpretations of pathogenicity in the databases. Conclusions: We demonstrated the pathogenicity of the three novel splicing variants, all with strong impact on galactosylceramidase function. We also concluded that the c.956A>G missense variant is a hypomorph usually underlying the later-onset, milder phenotypes of KD. Our results stress the importance of integrated approaches combining clinical, biochemical, and genetic testing to obtain a definitive diagnosis of lysosomal diseases.
Source: Biomedicines
Authors: María Domínguez-Ruiz, Juan Luis Chico, Laura López-Marín, Sinziana Stanescu, Pablo Crujeiras, Daniel Rodrigues, María-Elena de las Heras-Alonso, Rosana Torremocha, María del Mar Meijón-Ortigueira, Patricia Muñoz-Díez, Val F. Lanza, Cristóbal Colón, Jesús Villarrubia, Amaya Belanger, Francisco J. del Castillo
Institutions: Centre for Biomedical Network Research on Rare Diseases, Instituto Ramón y Cajal de Investigación Sanitaria, Hospital Universitario Ramón y Cajal, Universidad de Alcalá, Hospital Infantil Universitario Niño Jesús, Centro de Investigación Biomédica en Red, Instituto de Investigación Sanitaria de Santiago, Centro de Investigación Biomédica en Red Enfermedades Infecciosas
Language: English
Subfield: Physiology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $3,137
Funder: Sanofi
OpenAlex ID: W4417455696
FWCI:
Cites:
Cited by:
Related to:
